526

N . N . A B U M R A D A N D OTHERS
human volunteers fasted overnight. The reason for these conflicting results may be attributed to the inability to measure portal-vein glutamine levels and, hence, the inability of the investigators to differentiate between substrate balances across the gut, liver, or other extrahepatic splanchnic tissues, such as the spleen, mesenteric fat or the pancreas.
Studies from our laboratory in the multiple-catheterized conscious dog established the capacity of the gut to extract glutamine from the blood at a rate comparable with that of the liver . In these studies we measured the arterial-portal venous differences of glutamine and we estimated blood flow across the portal-drained viscera either using the indocyanine green clearance method, or using doppler flow-meters (Williams et al. 1992) . Further, these studies showed that progressive fasting (up to 4 d) was associated with enhanced utilization of glutamine by the gut. We also showed that fasting was associated with a switch from a predominant production of alanine by the gut to that of NH4+. These findings would suggest that overnight fasting is associated with a predominant dependence on transaminase enzymes by the intestinal mucosa, but as fasting progresses there is a change to dependence on the glutaminase enzymes, with enhanced production of NH4+. The mechanism for all these changes remains to be determined. The work from our laboratory, as well as from others (Welbourne, 1987) , would suggest that the increased uptake of glutamine seen during fasting may be secondary to the prevailing mild but compensated metabolic acidosis associated with short-term fasting (Cersosimo et al. 1986 ). Other potential causes could include changes in the hormonal milieu, such as a decrease in plasma insulin and increases in plasma glucagon and corticosteroids that are seen with progressive fasting.
Effect of exercise
Most of the studies relating to the various metabolic changes that occur with exercise have focused their attention on the role of the liver and skeletal muscle. Little information is available, however, on the role of the intestines, and in particular on glutamine metabolism, during periods of acute exercise. Wasserman et al. (1991a,b) examined amino acid balances in a conscious dog model after an overnight fast, during a basal period and during 150 min of moderately-intense treadmill exercise (at 100 d m i n , 12% gradient). These authors showed that exercise was associated with a 17% reduction in blood glutamine and an approximately 80% enhancement in glutamine extraction by the gut as shown in Fig. 1 . This increase was associated also with increased percentage extraction (from approximately 8 during the basal period to approximately 16 after 60 min of exercise). These changes were associated with transient increases in net gut output of NH4+, with changes in net output of alanine. Plasma NH4+ did not change, while plasma alanine levels decreased by 30%. The changes in the gut handling of other amino acids were also interesting. The gut output of total a-NH2-N (derived as the sum of all other amino acids released) during exercise exceeded that net uptake of glutamine by a ratio of 3:l. Thus, we suggest that the changes in intestinal glutamine metabolism are intimately tied to the needs of the liver for substrates, and in particular amino acids, to meet the increased demands for enhanced glucose utilization during exercise. Under such conditions, the demands for increased delivery of gluconeogenic amino acids is augmented, and in this respect, the gut acts as a reservoir and a major source of these amino acids. The exercise protocol used in this study elicited significant increases in plasma glucagon, epinephrine, norepinephrine and a 50% reduction in circulating plasma insulin levels. Based on observations cited here, it is quite clear, however, that the changes in gut glutamine extraction can be attributed entirely to the increased plasma glucagon associated with exercise (Wasserman et al. 1989a,b) .
Effect of insulin
The effect of physiological changes in plasma insulin on amino acids has not been addressed previously. As a result, we examined the effects of selective insulin withdrawal and selective hyperinsulinaemia (2-3-fold basal values) in a group of conscious dogs. These studies were accomplished by an intravenous infusion of cyclic somatostatin, to inhibit the secretion of insulin and glucagon, with simultaneous infusions of intraportal glucagon at a rate of 0.50-0.60 ng/kg per min intended to achieve arterial plasma glucagon levels at or near basal levels. In one set of animals intraportal insulin (at a rate of 600 pg/kg per min) was co-infused to establish approximately 2-3-fold hyperinsulinaemia; euglycaemia was maintained by a variable infusion of glucose. In another set of animals intravenous somatostatin was administered in conjunction with intraportal glucagon (at the rate suggested previously), but with no insulin infusion. This rendered the animals with acute insulin deficiency. The findings (except those for glutamine) from both studies have been published already (Abumrad et al. 1982) . Our studies showed . These rates were chosen to establish the arterial insulin levels near basal levels (approximately 15 pU/ml) and the plasma glucagon levels to be 3-4-fold basal levels (250-300 pg/ml). Net gut glutamine uptake was determined during a 40 min basal period and during a 3 h hyperglucagonaemic period. The values represent the average of at least four to eight determinations during each period. Values are means with their standard errors represented by vertical bars. Mean value was significantly different from basal value:
*P<O.OS.
that neither acute insulin deficiency nor physiological hyperinsulinaemia was associated with any significant alterations in either plasma glutamine or changes in the rates of glutamine extraction by the gut. Hyperinsulinaemia was associated with significant decreases (10-35%) in plasma amino acids, while selective insulin deficiency for 4 h was associated with significant increases in various plasma amino acids, in particular the branched-chain amino acids, leucine, isoleucine and valine. Taken together, these results indicate that physiological changes in plasma insulin are not likely to result in any significant alterations in intestinal glutamine metabolism.
Effect of glucagon
One of the hallmarks of the stress response is an increase in plasma glucagon. In order to address the role of physiological changes in plasma glucagon in relation to intestinal glutamine metabolism, we carried out a set of studies identical to those described previously. A group of conscious animals received an intravenous infusion of cyclic somatostatin with simultaneous infusion of intraportal insulin (to achieve basal levels) and glucagon (3.0-3.5 ng/kg per min) intended to achieve 4-fold basal arterial glucagon levels (an increase to approximately 300 pg/ml). Hyperglucagonaemia was associated with a 70% increase in glutamine extraction by the intestine (as shown in Fig. 2 (Geer et al. 1987) . The mechanism of such a stimulation remains undetermined. Recent unpublished preliminary findings, also carried out using dogs fasted overnight and for 4 d (R. J. Geer and N. N. Abumrad, unpublished results) suggest that glucagon's stimulatory effect on intestinal glutamine metabolism is most probably mediated by increases in the Na+-H+ transporter. The significance of these findings, however, remains to be determined.
Effect of corticosteroids
The role that corticosteroids play in modulating glutamine utilization by the gut has been the subject of several studies in our laboratory. Two such representative studies were carried out by McCallister et al. (1983) and by Miller et al. (1984) . In these studies the animals were treated with dexamethasone (1.0 mgld for 2-4 d). Glutamine balance across the portal-drained viscera was determined following an overnight fast. These studies showed that high dexamethasone treatment resulted in an approximately 2-fold increase in glutamine uptake by the gut. Recent studies from our laboratory suggest that this effect might be related to changes in the intralumen pH of the intestinal mucosa, and that such changes are in many ways identical to those seen with fasting (N. Yazigi, N. Okamura and N. N. Abumrad, unpublished results). It remains to be determined, however, whether these effects are additive.
Effect of hypoglycaemia
Over the past few years, our laboratory has been studying metabolic responses to insulin-induced hypoglycaemia. Most of the studies were performed using the conscious dog model (Hourani et al. 1990a,b; Molina et al. 1993) , with some studies carried out in the rat (Molina & Abumrad, 19946) . Our findings were consistent with a significant enhancement in whole-body proteolysis during a hypoglycaemic episode. When studying the source of the amino acids released during a hypoglycaemic episode we were surprised to find that the gut was the major source of these substrates. Hypoglycaemia was associated with a significant release of all the investigated amino acids across the gastrointestinal tract, except for glutamine. The gut uptake of glutamine declined from an average of 1.6 (SE 0-3) pmoykg per min to almost 0.1 (SE 0.2) prnoykg per min, as shown in Fig. 3 . Here again, the mechanism of these changes remains elusive. It is of interest to note that hypoglycaemia is associated with significant increases in plasma glucagon, cortisol, epinephrine, norepinephrine, and p-endorphin. In an attempt to examine whether any of these hormones played a role in the pathogenesis of the enhanced intestinal (and whole-body) proteolytic responses, we infused these hormones, singly and in combination (N. Yazigi, N. Okamura and N. N. Abumrad, unpublished results), to simulate the prevailing plasma levels, and we failed to reproduce any of the protein catabolic responses associated with hypoglycaemia. As a result, we investigated the role that the central nervous system (CNS) played in modulating this response. In subsequent studies, similar to those described previously, we placed catheters in the internal carotid and vertebral arteries of dogs. They were allowed to recover for a period of 3 weeks post-operatively, before studying them in the conscious state. The animals were then subjected to hypoglycaemia (plasma glucose levels 400 (SE 30) mg/l), with the exogenous infusion of insulin. One group was simultaneously given enough glucose through both carotid and vertebral arteries to maintain approximate CNS-euglycaemia (i.e. the CNS glucose levels were approximately basal, but the rest of the body was subjected to hypoglycaemia). The other group of animals, received saline (9 g NaCV1) instead, thus rendering the animals totally hypoglycaemic (i.e. CNS + rest of the body).
Our findings indicate that the group that was allowed to maintain CNS glucopenia showed the same enhanced proteolysis seen in the previous studies, with the gut responsible for most of the increased proteolytic response mentioned previously. However, the group of animals that had the CNS protected against hypoglycaemia failed to show any increased proteolytic response by the body and, most importantly, the gut did not increase its output of amino acids, even though the general arterial circulation (except for the brain) was subjected to hypoglycaemia. These findings indicated conclusively that the CNS was the primary triggering organ responsible for the enhanced proteolysis by the body and by the gut during a period of hypoglycaemia. Presently our laboratory is actively pursuing the various potential mediators involved in this CNSelicited response.
Role of cytokines
Several studies have suggested that sepsis is associated with decreased uptake of glutamine by the gut and with decreased transport of glutamine across the brush-border membranes (Souba et al. 198.5) . It has been suggested that most, if not all, these responses are mediated by the cytokines released during a septic episode. Most notable among these are interleukin-1 (IL-1) and tumour necrosis factor a (TNFa). Fukushima et al. (1992) , examined the effects of IL-1 and TNFa on various haemodynamic variables and inter-organ fluxes of amino acids. IL-1 infusion resulted in a hyperdynamic state, with no significant alterations in the gut balances of amino acids. IL-1 infusion, however, resulted in significant elevations (34fold) in gut glutamine uptake, as shown in Fig. 4 . On the other hand, TNFa infusion did not cause a hyperdynamic state, and it did not alter the uptake of amino acids, including glutamine. These findings showed that these cytokines had differential effects on the uptake of glutamine by the gut.
In conclusion, it appears that the gut handling of glutamine is highly dependent on the prevailing hormonal and cytokine conditions. There is also some evidence to suggest that the gut utilization of glutamine, and other amino acids, may be highly dependent also on the signals received from the CNS. In the case of hypoglycaemia we presented convincing data to suggest that all the signals for enhanced proteolysis, and especially the output of amino acids by the gut, during a period of hypoglycaemia are all neural in origin (Molina & Abumrad, 1994a) . These are not mediated by the classic hormonal changes, i.e. changes in the circulating levels of insulin, glucagon, cortisol and catecholamines. Thus, more work is required to address the various factors that influence the gut handling of glutamine and other amino acids in vivo.
